-
Our Mission
Discover, develop, manufacture and commercialize innovative and safe medicines, in particular, medicines that target high unmet medical needs arising from the complications of hypoxia (oxygen deprivation). We seek to make these treatments available to patients across the globe, including emerging economies.
Time is Life when it comes to Oxygen
We are responding to COVID-19
Our lead investigational product, LEAF-4L6715, is currently being studied in a Phase I/II clinical trial of patients with COVID-19.
-
Time Is Life
When confronted with oxygen deprivation (hypoxia), Time is Life. Our team, together with our partners from the public and private sectors, are working tirelessly to urgently bring these life-saving medicines to patients. -
Carefully Crafted
We achieve this through the development of innovative, effective and safe medicines. -
Global Impact
Our core belief and our dedication is to the value proposition of Lifting and Empowering All Families.
-
"The world is increasingly entering an era of biological complexity in which we are now witnessing the emergence of dangerous biothreats capable of spreading rapidly at a global scale. LEAF4Life is dedicated to discovering and developing novel medicines that effectively address diseases emerging from these threats. Today, we are addressing COVID-19."
Clet Niyikiza, PhDFounder, President & Chief Executive Officer
-
The next generation of Biodefense Medicines
Our core belief is that Time is Life and our dedication is to the value proposition of Lifting and Empowering All Families.
We achieve this through the development of innovative, effective and safe medicines. These medicines aim to effectively mitigate the threats posed by dangerous pathogens including those of epidemic or pandemic proportions.